0001213900-23-098497.txt : 20231226 0001213900-23-098497.hdr.sgml : 20231226 20231226130948 ACCESSION NUMBER: 0001213900-23-098497 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231223 FILED AS OF DATE: 20231226 DATE AS OF CHANGE: 20231226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Shane Aaron CENTRAL INDEX KEY: 0001889332 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 231512421 MAIL ADDRESS: STREET 1: 930 TAHOE BLVD. STREET 2: SUITE 802-433 CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 4 1 ownership.xml X0508 4 2023-12-23 0 0001728328 InMed Pharmaceuticals Inc. INM 0001889332 Johnson Shane Aaron C/O INMED PHARMACEUTICALS INC. 310-815 WEST HASTINGS ST. VANCOUVER A1 V6C1B4 BRITISH COLUMBIA, CANADA 0 1 0 0 Sr VP & General Manager 0 Employee Stock Option (Right to Buy) 0.37 2023-12-23 4 A 0 40000 0.00 A 2028-12-22 Common shares 40000 48000 D The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month). /s/ Eric A Adams, attorney-in-fact for Mr. Shane Johnson 2023-12-26